Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/124308| Title: | Comparison of 68Ga-FAPI and 18F-DOPA PET/CT in patients with medullary thyroid cancer |
| Author(s): | Hescheler, Daniel A. Atiyat, Dogan Lorenz, Kerstin Heinzel, Alexander Reschke, Philipp Almaguel, Frankis G. Petersen, Manuela Eppard, Elisabeth Wybranska, Joanna Wuestemann, Jan Kreißl, Michael |
| Issue Date: | 2026 |
| Type: | Article |
| Language: | English |
| Abstract: | Introduction: Accurate staging is paramount for the effective management of medullary thyroid carcinoma (MTC). Imaging cancer-associated fibroblasts utilizing Gallium-68-labeled fibroblast activation protein inhibitors (FAPI) presents a novel approach for molecular imaging across various cancers, including MTC. This study aimed to compare the diagnostic accuracy of FAP-targeted imaging (68Ga-RTX-1363S, abbreviated as 68Ga-FAPI) with the established imaging standard, 18F-DOPA, for the detection of metastases in patients with MTC. Methods: This retrospective study compared 18F-DOPA- and 68Ga-FAPI PET/CT imaging using per-patient and per-lesion analyses in patients with recurrent MTC. Imaging findings were correlated with morphological imaging (CT/MRI/sonography) or histopathology as gold standard. Quantitative assessment included a comparison of standardized uptake values (SUVs) and tumor-to-background ratios (TBRs). Results: Nine patients (mean age 55 years, range 34–80 years) with 62 lesions were included. Compared to 18F-DOPA, 68Ga-FAPI showed significantly higher lesion detection rates for lymph node metastases (true-positive [TP] rate: 100% [8/8] vs. 50% [4/8]; TBR: 10.9 vs. 6.9), lung metastases (TP rate: 85.7% [12/14] vs. 42.9% [6/14]; TBR: 6.1 vs. 3.6), and liver metastases (TP rate: 100% [22/22] vs. 23% [5/22]; TBR: 24.1 vs. 2.7). Conclusion: In direct comparison, 68Ga-FAPI detected a higher number of metastases with higher TBR values. 68Ga-FAPI PET/CT holds promise for improving staging in MTC. However, these findings necessitate confirmation in a larger, prospective study. |
| URI: | https://opendata.uni-halle.de//handle/1981185920/126242 http://dx.doi.org/10.25673/124308 |
| Open Access: | Open access publication |
| License: | (CC BY 4.0) Creative Commons Attribution 4.0 |
| Journal Title: | Frontiers in endocrinology |
| Publisher: | Frontiers Research Foundation |
| Publisher Place: | Lausanne |
| Volume: | 17 |
| Original Publication: | 10.3389/fendo.2026.1824054 |
| Appears in Collections: | Open Access Publikationen der MLU |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| fendo-17-1824054.pdf | 11.31 MB | Adobe PDF | ![]() View/Open |
Open access publication
